马斯克脑机接口，靠意念玩游戏只是基操，下一代设备性能翻三倍

Core Viewpoint - Neuralink's brain-computer interface technology is making significant strides, allowing paralyzed patients to control devices using their thoughts, marking a transformative step in medical technology and patient autonomy [5][32]. Group 1: Clinical Trials and User Experiences - As of now, 21 individuals are participating in Neuralink's Telepathy clinical trials, a notable increase from 12 participants last September [5]. - Early trial participants have experienced substantial changes in their daily lives, enabling them to browse the internet and play video games without physical movement [10]. - Users have reported that the technology can predict their intentions faster than they can consciously think, enhancing the control experience [12]. Group 2: User Testimonials - Nick, a participant who has been unable to move for four years, can now control a robotic arm for basic tasks using only his thoughts, achieving a data transmission rate exceeding 10 bits per second [12][29]. - Sebastian, a medical student with spinal cord injury, uses Neuralink for up to 17 hours daily, facilitating his academic work [16]. - Audrey, the first female participant, has created art using the technology, showcasing its potential for creative expression [20]. Group 3: Technological Advancements - Neuralink's core technology translates brain signals into computer commands, allowing users to interact with digital devices despite physical limitations [31]. - The next-generation device is expected to be three times more powerful than the current version and is anticipated to launch in 2026 [32]. - Neuralink is also developing a device called Blindsight, aimed at restoring vision for completely blind patients by transmitting image data directly to the brain [33]. Group 4: Future Developments and Funding - The company plans to deploy faster surgical robots to enhance the efficiency and safety of implantation procedures [34]. - Neuralink secured $650 million in funding last June to support ongoing research and commercialization efforts [34].